Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 101033
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.101033
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.101033
Table 6 Management of dry eyes
Category | Ref. | Management tool | Details description |
Management strategies | Akpek et al[118] | Topical cyclosporine 0.1% | A water-free cyclosporine formulation that improves the ocular surface in moderate-to-severe dry eye |
Fogagnolo et al[124] | Hyaluronic acid and ginkgo biloba drops | Effective in improving symptoms, especially post-cataract surgery | |
Wirta et al[131] | Recombinant human nerve growth factor | Promising in treating moderate-to-severe dry eye by enhancing corneal nerve regeneration | |
Hu et al[138] | Mesenchymal stem cells | Shows promise in managing Sjögren's syndrome, potentially aiding in ocular surface repair | |
Surgical options | Wang et al[136] | Punctal cauterization | Heat treatment that is useful for severe dry eye, particularly in preventing scarring |
Ji et al[139] | High-frequency radiowave electrosurgery | Improves conjunctivochalasis, reducing symptoms and improving management outcomes | |
Post-COVID-19 Considerations | Castillo et al[144] | Telehealthcare | Utilized to mitigate DED-linked ocular morbidity, particularly relevant post-COVID-19 |
- Citation: Musa M, Suleman A, Okechukwu C, Bale BI, Gagliano C, D’Esposito F, Zeppieri M. Diagnostic methods for managing dry eyes. World J Methodol 2025; 15(4): 101033
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/101033.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.101033